ATE496610T1 - Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften - Google Patents

Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften

Info

Publication number
ATE496610T1
ATE496610T1 AT04723696T AT04723696T ATE496610T1 AT E496610 T1 ATE496610 T1 AT E496610T1 AT 04723696 T AT04723696 T AT 04723696T AT 04723696 T AT04723696 T AT 04723696T AT E496610 T1 ATE496610 T1 AT E496610T1
Authority
AT
Austria
Prior art keywords
antiallergic
inflammatory properties
specific
keratolytic composition
keratolytic
Prior art date
Application number
AT04723696T
Other languages
English (en)
Inventor
Medasani Munisekhar
Original Assignee
Medasani Munisekhar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medasani Munisekhar filed Critical Medasani Munisekhar
Application granted granted Critical
Publication of ATE496610T1 publication Critical patent/ATE496610T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AT04723696T 2003-03-27 2004-03-26 Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften ATE496610T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN185KO2003 2003-03-27
PCT/IN2004/000069 WO2004084855A1 (en) 2003-03-27 2004-03-26 Keratolytic composition with anti-allergic anti-inflammatory properties

Publications (1)

Publication Number Publication Date
ATE496610T1 true ATE496610T1 (de) 2011-02-15

Family

ID=33042621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723696T ATE496610T1 (de) 2003-03-27 2004-03-26 Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften

Country Status (12)

Country Link
US (2) US20060241190A1 (de)
EP (1) EP1620063B1 (de)
JP (1) JP4955382B2 (de)
KR (1) KR101204581B1 (de)
CN (1) CN1774236B (de)
AT (1) ATE496610T1 (de)
AU (1) AU2004224521A1 (de)
CA (1) CA2520307A1 (de)
DE (1) DE602004031208D1 (de)
EA (1) EA011947B1 (de)
ES (1) ES2360290T3 (de)
WO (1) WO2004084855A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054312A1 (en) * 2004-11-16 2006-05-26 Munisekhar Medasani Ammonium compounds for treating psoriasis and eczema
US8709502B2 (en) 2005-09-23 2014-04-29 Chanel Parfums Beaute Extract of Vanilla planifolia
EP1928447B1 (de) * 2005-09-23 2016-02-17 Chanel Parfums Beauté Extrakt aus vanilla planifolia, verfahren zu seiner gewinnung und diesen enthaltende kosmetische oder dermatologische zusammensetzung
FR2891148B1 (fr) * 2005-09-23 2008-03-28 Chanel Parfums Beaute Soc Par Extrait de vanille, son procede d'obtention, et composition cosmetique ou dermatologique le contenant
GB0526283D0 (en) 2005-12-23 2006-02-01 Givaudan Sa Compositions
JP2008174495A (ja) * 2007-01-19 2008-07-31 Reverse Proteomics Research Institute Co Ltd 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
WO2015033351A1 (en) 2013-09-06 2015-03-12 Jubilant Life Sciences Limited Anti-dandruff compositions and hair care formulations containing zinc pyrithione and quaternary ammonium salt
US20150072026A1 (en) * 2013-09-07 2015-03-12 Yunyuan Li Anti-inflammatory ion and uses thereof
CN103784641A (zh) * 2014-02-08 2014-05-14 张孝昌 一种治疗牛皮癣的中药
CN103977262A (zh) * 2014-06-06 2014-08-13 马朝富 一种治疗肺结核病的纯中药制剂及其制备方法
EP3011959A1 (de) 2014-10-23 2016-04-27 Santen SAS Quaternäre Ammoniumverbindung zur Verwendung als Proteinkinase-C-Alpha-Hemmer
WO2017146602A1 (en) * 2016-02-24 2017-08-31 Arcasiu Nicolae Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
WO2018083675A1 (en) 2016-11-07 2018-05-11 Jubilant Life Sciences Limited Synergistic antimicrobial compositions
EP3641725A1 (de) 2017-06-23 2020-04-29 The Procter and Gamble Company Zusammensetzung und verfahren zur verbesserung der erscheinung der haut
PL233723B1 (pl) * 2017-09-12 2019-11-29 Politechnika Lodzka Naturalny krem pielegnacyjny
CN107582926A (zh) * 2017-09-26 2018-01-16 黄经卫 一种治疗牛皮癣的中药组合物
EP3817717A1 (de) 2018-07-03 2021-05-12 The Procter & Gamble Company Verfahren zur behandlung einer hautkrankheit
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3212970A (en) * 1960-02-04 1965-10-19 Glasser Joseph Treatment of psoriasis
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5104645A (en) * 1990-02-02 1992-04-14 The Proctor & Gamble Company Antidandruff shampoo compositions
US5567420A (en) * 1994-11-16 1996-10-22 Mceleney; John Lotion which is temporarily colored upon application
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
JP4299374B2 (ja) * 1996-10-08 2009-07-22 高砂香料工業株式会社 細胞賦活剤及びその応用
US20030104018A1 (en) * 1996-12-31 2003-06-05 Griscom Bettle Skin product having micro-spheres, and processes for the production thereof
JPH1160456A (ja) * 1997-08-18 1999-03-02 Maguoole Sci Kk 皮膚用入浴剤及び皮膚外用剤並びにボディソープ
US20020168423A1 (en) * 1997-12-19 2002-11-14 Wurzburger Stephen Ray High strength liquid antiseptic
GB9727053D0 (en) 1997-12-22 1998-02-18 Edko Trading Representation Pharmaceutical compositions
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
AU5087199A (en) * 1998-06-30 2000-01-17 American Medical Research, Inc. Method of treating topical ailments
DE19842787A1 (de) * 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
US6270781B1 (en) * 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
JP2000319171A (ja) * 1999-03-03 2000-11-21 Nof Corp 殺菌性皮膚外用剤組成物
DE10044382A1 (de) * 2000-09-08 2002-04-04 Haarmann & Reimer Gmbh Pflegemittel
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
EP1250915A1 (de) * 2001-04-19 2002-10-23 Beiersdorf Aktiengesellschaft Kosmetische und dermatologische Zubereitungen, enthaltend erhöhte Elektrolytkonzentrationen

Also Published As

Publication number Publication date
US20060241190A1 (en) 2006-10-26
WO2004084855A1 (en) 2004-10-07
EP1620063A1 (de) 2006-02-01
AU2004224521A1 (en) 2004-10-07
KR20060007007A (ko) 2006-01-23
JP4955382B2 (ja) 2012-06-20
EP1620063B1 (de) 2011-01-26
EA200501439A1 (ru) 2006-04-28
DE602004031208D1 (de) 2011-03-10
US20150164941A1 (en) 2015-06-18
EA011947B1 (ru) 2009-06-30
JP2008500261A (ja) 2008-01-10
KR101204581B1 (ko) 2012-11-26
CN1774236A (zh) 2006-05-17
CA2520307A1 (en) 2004-10-07
ES2360290T3 (es) 2011-06-02
CN1774236B (zh) 2013-03-27
US10179148B2 (en) 2019-01-15

Similar Documents

Publication Publication Date Title
ATE496610T1 (de) Keratolytische zusammensetzung mit antiallergischen und entzündungshemmenden eigenschaften
SE0101387D0 (sv) Novel compounds
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BR0308787A (pt) Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona
SE0001899D0 (sv) New compounds
SE0401342D0 (sv) Therapeutic compounds
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
MY130441A (en) Solutions containing epinastin
SG155181A1 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE9802206D0 (sv) Novel compounds
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
BR0315878A (pt) Melatonina em formulações cosméticas
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
DK1242410T3 (da) Nye forbindelser
TW200517137A (en) Method for decreasing sebum production
BR0114814A (pt) Composições compreendendo composto de modafinila e seu uso
ATE388714T1 (de) Zusammensetzung umfassend nadh/nadph
ATE259813T1 (de) Triazolopyrimidinderivate
SE0400027D0 (sv) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
DE60005517D1 (de) Kaliumkanal-blockierende mittel
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties